Skip to main content

Billiontoone Inc - Class A

Exchange: NASDAQSector: HealthcareIndustry: Diagnostics & Research

Billiontoone Inc - Class A

Did you know?

Price sits at 20% of its 52-week range.

Current Price

$77.49

+3.25%

GoodMoat Value

$24.60

68.2% overvalued
Profile
Valuation (TTM)
Market Cap$3.55B
P/E-158.74
EV
P/B7.39
Shares Out45.77M
P/Sales15.79
Revenue$224.65M
EV/EBITDA336.01

Billiontoone Inc - Class A (BLLN) Financial Statements

BLLN Financial Data

EBITDA$9.40M
Revenue (TTM)$224.65M
Gross Profit (TTM)$152.74M
Gross Margin
Operating Margin5.25%
ROE0.04%
ROA0.03%
Debt/Equity0.23
Current Ratio11.69
FCF$15.71M
FCF Yield0.44%
Piotroski F-Score
Rev/Share (TTM)$4.91
50-Day MA$77.40
200-Day MA
Shares Outstanding0.05B

BLLN Computed Insights

FCF$15.71M
FCF Growth Rate
EPS Growth (CAGR)
WACC10.00%

Income Statement

Balance Sheet

Cash Flow Statement

BLLN Financial Statements & Data

Billiontoone Inc - Class A (BLLN) financial data including income statement, balance sheet, and cash flow statement. This page provides a comprehensive view of Billiontoone Inc - Class A's financial performance and position as a Healthcare company.

Trailing twelve-month (TTM) revenue is $224.65M. Gross profit (TTM) is $152.74M. EBITDA is $9.40M. Earnings per share (EPS) is $0.14. The P/E ratio is -158.74. Market capitalization is $3.55B.

Free cash flow (FCF) is $15.71M. Weighted average cost of capital (WACC) is 10.00%.

Historical revenue data covers 3 years from FY23 to FY25. Net income history spans 3 years. Free cash flow and capital expenditure data spans 3 years. GoodMoat displays interactive charts for revenue, net income, FCF vs CAPEX, and cash-to-debt ratios to help investors identify financial trends.

Use Billiontoone Inc - Class A's financial data to assess the company's earnings quality, balance sheet health, and cash generation. Compare key metrics across periods to identify trends before making investment decisions with GoodMoat's valuation tools.